CoChat

Effective delivery of large genes to the retina by dual AAV vectors

Open access

The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.

Abstract

Retinal gene therapy with adeno‐associated viral (AAV) vectors is safe and effective in humans. However, AAV's limited cargo capacity prevents its application to therapies of inherited retinal diseases due to mutations of genes over 5 kb, like Stargardt's disease (STGD) and Usher syndrome type IB (USH1B). Previous methods based on ‘forced’ packaging of large genes into AAV capsids may not be easily translated to the clinic due to the generation of genomes of heterogeneous size which raise safety concerns. Taking advantage of AAV's ability to concatemerize, we generated dual AAV vectors which reconstitute a large gene by either splicing (trans‐splicing), homologous recombination (overlapping), or a combination of the two (hybrid). We found that dual trans‐splicing and hybrid vectors transduce efficiently mouse and pig photoreceptors to levels that, albeit lower than those achieved with a single AAV, resulted in significant improvement of the retinal phenotype of mouse models of STGD and USH1B. Thus, dual AAV trans‐splicing or hybrid vectors are an attractive strategy for gene therapy of retinal diseases that require delivery of large genes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201302948

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 CDS, coding sequence; pA, poly-adenylation signal; SD, splicing donor signal; SA, splicing acceptor signal; AP, alkaline phosphatase recombinogenic region; AK, F1 phage recombinogenic region. Pointed lines show overlapping regions available for homologous recombination, dotted lines show the splicing occurring between SD and SA.
Figure 1 CDS, coding sequence; pA, poly-adenylation signal; SD, splicing donor signal; SA, splicing acceptor signal; AP, alkaline phosphatase recombinogenic region; AK, F1 phage recombinogenic region. Pointed lines show overlapping regions available for homologous recombination, dotted lines show the splicing occurring between SD and SA.CC BY · PubMed Central
Figure 2 A–F Western blot analysis of HEK293 cells infected with AAV2/2 vectors encoding for ABCA4 (A, D), MYO7A (B, E) and EGFP (C, F). The Western blot images (A-C) are representative of and the quantifications (D-F) are from n = 4 (A, C, D, F) or n = 3 (B, E) independent experiments. OZ, AAV oversize; OV, dual AAV overlapping; TS, dual AAV trans-splicing; AP, dual AAV hybrid AP; AK, dual AAV hybrid AK; TS-L, dual AAV trans-splicing EGFP with a combined genome size similar to OZ-EGFP; AK-L, dual AAV hybrid AK EGFP with a combined genome size similar to OZ-EGFP; 5′+3′, cells co-infected with 5′-and 3′-half vectors; 5′, control cells infected with the 5′-half vector; 3′, control cells infected with the 3′-half vector; α-EGFP, Western blot with anti-EGFP antibody; α-3xflag, Western blot with anti-3xflag antibody; α-Myo7a, Western blot with anti-Myo7a antibody; α-β-Tubulin, Western blot with anti-β-Tubulin antibody, used as loading control; α-Filamin A, Western blot with anti-Filamin A antibody, used as loading control. * P ANOVA < 0.05; ** P ANOVA < 0.001. A–C The arrows indicate full-length proteins, the micrograms of proteins loaded are depicted under each lane, the molecular weight ladder is depicted on the left. D–F Quantification of ABCA4 (D), MYO7A (E) and EGFP (F) protein bands. The intensity of the ABCA4, MYO7A and EGFP bands was divided by the intensity of the Filamin A (D, E) or Tubulin (F) bands. The histograms show the expression of proteins as a percentage relative to dual AAV trans-splicing (TS) vectors, the mean value is depicted above the corresponding bar. Values are represented as mean ± standard error of the mean (s.e.m.). Data information: (E) The asterisks represent significant differences with both OZ and AP. (D–F) More details on the TS and TS-L variability as well as on the statistical analysis including specific statistical values can be found in the Western blot and Statistical analysis paragraphs of the Materials and methods section, respectively.
Figure 2 A–F Western blot analysis of HEK293 cells infected with AAV2/2 vectors encoding for ABCA4 (A, D), MYO7A (B, E) and EGFP (C, F). The Western blot images (A-C) are representative of and the quantifications (D-F) are from n = 4 (A, C, D, F) or n = 3 (B, E) independent experiments. OZ, AAV oversize; OV, dual AAV overlapping; TS, dual AAV trans-splicing; AP, dual AAV hybrid AP; AK, dual AAV hybrid AK; TS-L, dual AAV trans-splicing EGFP with a combined genome size similar to OZ-EGFP; AK-L, dual AAV hybrid AK EGFP with a combined genome size similar to OZ-EGFP; 5′+3′, cells co-infected with 5′-and 3′-half vectors; 5′, control cells infected with the 5′-half vector; 3′, control cells infected with the 3′-half vector; α-EGFP, Western blot with anti-EGFP antibody; α-3xflag, Western blot with anti-3xflag antibody; α-Myo7a, Western blot with anti-Myo7a antibody; α-β-Tubulin, Western blot with anti-β-Tubulin antibody, used as loading control; α-Filamin A, Western blot with anti-Filamin A antibody, used as loading control. * P ANOVA < 0.05; ** P ANOVA < 0.001. A–C The arrows indicate full-length proteins, the micrograms of proteins loaded are depicted under each lane, the molecular weight ladder is depicted on the left. D–F Quantification of ABCA4 (D), MYO7A (E) and EGFP (F) protein bands. The intensity of the ABCA4, MYO7A and EGFP bands was divided by the intensity of the Filamin A (D, E) or Tubulin (F) bands. The histograms show the expression of proteins as a percentage relative to dual AAV trans-splicing (TS) vectors, the mean value is depicted above the corresponding bar. Values are represented as mean ± standard error of the mean (s.e.m.). Data information: (E) The asterisks represent significant differences with both OZ and AP. (D–F) More details on the TS and TS-L variability as well as on the statistical analysis including specific statistical values can be found in the Western blot and Statistical analysis paragraphs of the Materials and methods section, respectively.CC BY · PubMed Central
Figure 3 A–B Representative Western blot analysis of C57BL/6 (A) and Large White pig (B) retinal lysates 1 month following injection of dual AAV2/8 overlapping vectors encoding for ABCA4-3xflag (OV) or AAV2/8 vectors expressing EGFP (neg), under the control of the ubiquitous cytomegalovirus (CMV) promoter, the PR-specific Rhodopsin (RHO) and Rhodopsin kinase (RHOK) promoters, or the RPE-specific vitelliform macular dystrophy 2 (VMD2) promoter. The arrows indicate full-length proteins, the molecular weight ladder is depicted on the left, 150 μg of proteins were loaded in each lane. The number ( n) and percentage of ABCA4-positive retinas out of total retinas analyzed is depicted; α-3xflag, Western blot with anti-3xflag antibody; α-Dysferlin, Western blot with anti-Dysferlin antibody, used as loading control.
Figure 3 A–B Representative Western blot analysis of C57BL/6 (A) and Large White pig (B) retinal lysates 1 month following injection of dual AAV2/8 overlapping vectors encoding for ABCA4-3xflag (OV) or AAV2/8 vectors expressing EGFP (neg), under the control of the ubiquitous cytomegalovirus (CMV) promoter, the PR-specific Rhodopsin (RHO) and Rhodopsin kinase (RHOK) promoters, or the RPE-specific vitelliform macular dystrophy 2 (VMD2) promoter. The arrows indicate full-length proteins, the molecular weight ladder is depicted on the left, 150 μg of proteins were loaded in each lane. The number ( n) and percentage of ABCA4-positive retinas out of total retinas analyzed is depicted; α-3xflag, Western blot with anti-3xflag antibody; α-Dysferlin, Western blot with anti-Dysferlin antibody, used as loading control.CC BY · PubMed Central
Figure 4 EGFP protein quantification by ELISA of retinas from C57BL/6 mice 1 month following subretinal injection of AAV2/8 vectors encoding for EGFP under the control of the PR-specific Rhodopsin (RHO) promoter. The scatter plot depicts EGFP protein levels from each retina; the mean value for each group is depicted and indicated with a solid line. The number ( n) of eyes analyzed is depicted under the x axis. ** P ANOVA<0.001. More details on the statistical analysis including specific statistical values can be found in the Statistical analysis paragraph of the Materials and methods section.Fluorescence analysis of retinal cryosections from Large White pigs 1 month following subretinal injection of AAV2/8 vectors encoding for EGFP under the control of the PR-specific RHO promoter. The pictures are representative of: n = 4 or n = 3 eyes injected with dual AAV TS or hybrid AK, respectively. The scale bar (100 μm) is depicted in the figure. NS, AAV normal size; TS, dual AAV trans-splicing; AK, dual AAV hybrid AK; DAPI, 4′,6′-diamidino-2-phenylindole staining; EGFP, native EGFP fluorescence; Merge, overlay of DAPI and EGFP pictures; RPE, retinal pigmented epithelium; PR, photoreceptors.
Figure 4 EGFP protein quantification by ELISA of retinas from C57BL/6 mice 1 month following subretinal injection of AAV2/8 vectors encoding for EGFP under the control of the PR-specific Rhodopsin (RHO) promoter. The scatter plot depicts EGFP protein levels from each retina; the mean value for each group is depicted and indicated with a solid line. The number ( n) of eyes analyzed is depicted under the x axis. ** P ANOVA<0.001. More details on the statistical analysis including specific statistical values can be found in the Statistical analysis paragraph of the Materials and methods section.Fluorescence analysis of retinal cryosections from Large White pigs 1 month following subretinal injection of AAV2/8 vectors encoding for EGFP under the control of the PR-specific RHO promoter. The pictures are representative of: n = 4 or n = 3 eyes injected with dual AAV TS or hybrid AK, respectively. The scale bar (100 μm) is depicted in the figure. NS, AAV normal size; TS, dual AAV trans-splicing; AK, dual AAV hybrid AK; DAPI, 4′,6′-diamidino-2-phenylindole staining; EGFP, native EGFP fluorescence; Merge, overlay of DAPI and EGFP pictures; RPE, retinal pigmented epithelium; PR, photoreceptors.CC BY · PubMed Central
Figure 5 Representative Western blot analysis of C57BL/6 retinal lysates 1 month following the injection of dual AAV trans-splicing (TS) and hybrid AK (AK) vectors encoding for ABCA4 under the control of the PR-specific Rhodopsin promoter (RHO PROMOTER). The arrow points at full-length proteins, the molecular weight ladder is depicted on the left, 150 μg of protein were loaded in each lane. The number ( n) and percentage of ABCA4-positive retinas out of total retinas analyzed is depicted. AK, retinas injected with dual AAV hybrid AK vectors; TS, retinas injected with dual AAV TS vectors; neg, retinas injected with AAV vectors expressing EGFP, as negative controls; α-3xflag, Western blot with anti-3xflag antibody; α-Dysferlin, Western blot with anti-Dysferlin antibody, used as loading control.Representative pictures of immuno-electron microscopy analysis with anti-HA antibody of retinal sections from wild-type BALB/c (WT) and Abca4−/− mice injected with either dual AAV or with negative control vectors. The black dots represent the immuno-gold labelling of the ABCA4-HA protein. The scale bar (200 nm) is depicted in the figure.Representative pictures of transmission electron microscopy analysis showing lipofuscin granules content in the RPE of WT and Abca4−/− mice injected with either dual AAV or negative control vectors. The black arrows indicate lipofuscin granules. The scale bar (1.6 μm) is depicted in the figure.Quantification of the mean number of lipofuscin granules counted in at least 30 fields (25 μm2) for each sample. The number ( n) of eyes analyzed is depicted below each bar. The mean value is depicted above the corresponding bar. Values are represented as mean ± standard error of the mean (s.e.m.). * P ANOVA < 0.05; ** P ANOVA < 0.001. More details on the statistical analysis including specific statistical values can be found in the Statistical analysis paragraph of the Materials and methods section. Data information: (B-D) WT, BALB/c eyes; Abca4−/− neg, Abca4−/− eyes injected with either AAV vectors expressing EGFP ( n = 2) or the 5′-( n = 3) or 3′-( n = 4) half of the dual AAV hybrid AK vectors, as negative control (neg total n = 9); Abca4−/− AK-ABCA4, mice injected with dual AAV hybrid AK vectors; Abca4−/− TS-ABCA4, mice injected with dual AAV TS vectors.
Figure 5 Representative Western blot analysis of C57BL/6 retinal lysates 1 month following the injection of dual AAV trans-splicing (TS) and hybrid AK (AK) vectors encoding for ABCA4 under the control of the PR-specific Rhodopsin promoter (RHO PROMOTER). The arrow points at full-length proteins, the molecular weight ladder is depicted on the left, 150 μg of protein were loaded in each lane. The number ( n) and percentage of ABCA4-positive retinas out of total retinas analyzed is depicted. AK, retinas injected with dual AAV hybrid AK vectors; TS, retinas injected with dual AAV TS vectors; neg, retinas injected with AAV vectors expressing EGFP, as negative controls; α-3xflag, Western blot with anti-3xflag antibody; α-Dysferlin, Western blot with anti-Dysferlin antibody, used as loading control.Representative pictures of immuno-electron microscopy analysis with anti-HA antibody of retinal sections from wild-type BALB/c (WT) and Abca4−/− mice injected with either dual AAV or with negative control vectors. The black dots represent the immuno-gold labelling of the ABCA4-HA protein. The scale bar (200 nm) is depicted in the figure.Representative pictures of transmission electron microscopy analysis showing lipofuscin granules content in the RPE of WT and Abca4−/− mice injected with either dual AAV or negative control vectors. The black arrows indicate lipofuscin granules. The scale bar (1.6 μm) is depicted in the figure.Quantification of the mean number of lipofuscin granules counted in at least 30 fields (25 μm2) for each sample. The number ( n) of eyes analyzed is depicted below each bar. The mean value is depicted above the corresponding bar. Values are represented as mean ± standard error of the mean (s.e.m.). * P ANOVA < 0.05; ** P ANOVA < 0.001. More details on the statistical analysis including specific statistical values can be found in the Statistical analysis paragraph of the Materials and methods section. Data information: (B-D) WT, BALB/c eyes; Abca4−/− neg, Abca4−/− eyes injected with either AAV vectors expressing EGFP ( n = 2) or the 5′-( n = 3) or 3′-( n = 4) half of the dual AAV hybrid AK vectors, as negative control (neg total n = 9); Abca4−/− AK-ABCA4, mice injected with dual AAV hybrid AK vectors; Abca4−/− TS-ABCA4, mice injected with dual AAV TS vectors.CC BY · PubMed Central
Figure 6 Representative pictures of transmission electron microscopy analysis of retinal sections from wild-type BALB/c (WT) and Abca4−/− mice injected with dual AAV trans-splicing (TS-ABCA4) and hybrid AK vectors (AK-ABCA4) or with either AAV vectors expressing EGFP or 5′-or 3′-half of the dual hybrid AK vectors (neg), as negative controls. The dotted lines indicate the edges of RPE cells. The scale bar (3.8 μm) is depicted in the figure.Quantification of the mean RPE thickness counted in at least 30 fields for each sample. The number ( n) of eyes analyzed is depicted below each bar. Abca4−/− neg includes Abca4−/− mice injected with either AAV vectors expressing EGFP ( n = 2) or 5′-( n = 3) or 3′-( n = 4) half of the dual hybrid AK vectors (neg total n = 9). The mean value is depicted above the corresponding bar. Values are represented as mean ± standard error of the mean (s.e.m.). * P ANOVA < 0.05.Recovery from light desensitization in 3 month-old Abca4−/− and BALB/c mice at 6 weeks post-injection. The relative b-wave is the ratio between the post-and the pre-desensitization b-wave amplitudes both evoked by 1 cd s/m2. The time refers to the minutes post-desensitization. The mean recovery (%) at 60 min is depicted. Data information: (A-C) WT, BALB/c eyes ( n = 4); Abca4−/− TS-ABCA4, eyes injected with dual AAV TS vectors ( n = 5); Abca4−/− AK-ABCA4, AAV hybrid AK vectors ( n = 5); Abca4−/− neg, Abca4−/− mice either not injected ( n = 2) or injected with the 5′-half of the dual AAV TS ( n = 3) or hybrid AK ( n = 2) vectors (neg total n = 7). Values are represented as mean ± standard error of the mean (s.e.m.). * P ANOVA < 0.05. More details on the statistical analysis including specific statistical values can be found in the Statistical analysis paragraph of the Materials and methods section.
Figure 6 Representative pictures of transmission electron microscopy analysis of retinal sections from wild-type BALB/c (WT) and Abca4−/− mice injected with dual AAV trans-splicing (TS-ABCA4) and hybrid AK vectors (AK-ABCA4) or with either AAV vectors expressing EGFP or 5′-or 3′-half of the dual hybrid AK vectors (neg), as negative controls. The dotted lines indicate the edges of RPE cells. The scale bar (3.8 μm) is depicted in the figure.Quantification of the mean RPE thickness counted in at least 30 fields for each sample. The number ( n) of eyes analyzed is depicted below each bar. Abca4−/− neg includes Abca4−/− mice injected with either AAV vectors expressing EGFP ( n = 2) or 5′-( n = 3) or 3′-( n = 4) half of the dual hybrid AK vectors (neg total n = 9). The mean value is depicted above the corresponding bar. Values are represented as mean ± standard error of the mean (s.e.m.). * P ANOVA < 0.05.Recovery from light desensitization in 3 month-old Abca4−/− and BALB/c mice at 6 weeks post-injection. The relative b-wave is the ratio between the post-and the pre-desensitization b-wave amplitudes both evoked by 1 cd s/m2. The time refers to the minutes post-desensitization. The mean recovery (%) at 60 min is depicted. Data information: (A-C) WT, BALB/c eyes ( n = 4); Abca4−/− TS-ABCA4, eyes injected with dual AAV TS vectors ( n = 5); Abca4−/− AK-ABCA4, AAV hybrid AK vectors ( n = 5); Abca4−/− neg, Abca4−/− mice either not injected ( n = 2) or injected with the 5′-half of the dual AAV TS ( n = 3) or hybrid AK ( n = 2) vectors (neg total n = 7). Values are represented as mean ± standard error of the mean (s.e.m.). * P ANOVA < 0.05. More details on the statistical analysis including specific statistical values can be found in the Statistical analysis paragraph of the Materials and methods section.CC BY · PubMed Central
Figure 7 Representative Western blot analysis of C57BL/6 eyecups 1 month following the injection of dual AAV trans-splicing (TS) and hybrid AK (AK) vectors encoding for MYO7A-HA under the control of the ubiquitous chicken beta-actin (CBA) promoter. The arrow indicates full-length proteins, the molecular weight ladder is depicted on the left, 100 μg of proteins were loaded in each lane. The number ( n) and percentage of MYO7A-positive eyecups out of total eyecups analyzed is depicted. AK, eyes injected with dual AAV hybrid AK vectors; TS, eyes injected with dual AAV TS vectors; neg, eyes injected with either 5′-or 3′-half of the dual AAV TS and hybrid AK vectors; α-HA, Western blot with anti-hemagglutinin (HA) antibody; α-Dysferlin, Western blot with anti-Dysferlin antibody, used as loading control.Quantification of MYO7A levels expressed from dual AAV vectors in sh1−/− eyecups relative to endogenous Myo7a expressed in littermate sh1+/– eyecups. sh1−/− eyes were injected with dual AAV TS and hybrid AK vectors encoding MYO7A under the control of the CBA promoter and analyzed 1.5 months later. sh1+/– eyes were injected with AAV vectors expressing EGFP. The number ( n) of eyes analyzed is depicted below each bar. The quantification was performed by Western blot analysis using the anti-Myo7a antibody and measurements of MYO7A and Myo7a band intensities normalized to Dysferlin. The histograms show the expression of MYO7A protein as percentage relative to sh1+/– Myo7a; the mean value is depicted above the corresponding bars. Values are represented as mean ± standard error of the mean (s.e.m.).
Figure 7 Representative Western blot analysis of C57BL/6 eyecups 1 month following the injection of dual AAV trans-splicing (TS) and hybrid AK (AK) vectors encoding for MYO7A-HA under the control of the ubiquitous chicken beta-actin (CBA) promoter. The arrow indicates full-length proteins, the molecular weight ladder is depicted on the left, 100 μg of proteins were loaded in each lane. The number ( n) and percentage of MYO7A-positive eyecups out of total eyecups analyzed is depicted. AK, eyes injected with dual AAV hybrid AK vectors; TS, eyes injected with dual AAV TS vectors; neg, eyes injected with either 5′-or 3′-half of the dual AAV TS and hybrid AK vectors; α-HA, Western blot with anti-hemagglutinin (HA) antibody; α-Dysferlin, Western blot with anti-Dysferlin antibody, used as loading control.Quantification of MYO7A levels expressed from dual AAV vectors in sh1−/− eyecups relative to endogenous Myo7a expressed in littermate sh1+/– eyecups. sh1−/− eyes were injected with dual AAV TS and hybrid AK vectors encoding MYO7A under the control of the CBA promoter and analyzed 1.5 months later. sh1+/– eyes were injected with AAV vectors expressing EGFP. The number ( n) of eyes analyzed is depicted below each bar. The quantification was performed by Western blot analysis using the anti-Myo7a antibody and measurements of MYO7A and Myo7a band intensities normalized to Dysferlin. The histograms show the expression of MYO7A protein as percentage relative to sh1+/– Myo7a; the mean value is depicted above the corresponding bars. Values are represented as mean ± standard error of the mean (s.e.m.).CC BY · PubMed Central
Figure 8 Semi-thin retinal sections representative of both sh1+/+ and sh1+/– eyes ( sh1+/+) injected with AAV vectors expressing EGFP and of sh1−/− eyes injected with dual AAV trans-splicing (TS-MYO7A), hybrid AK (AK-MYO7A) or the 5′-or 3′-half vectors (neg), as negative controls. The arrows point at correctly localized melanosomes, the scale bar (10 μm) is depicted in the figure.Quantification of melanosome localization in the RPE villi of sh1 mice 2–3 months following subretinal delivery of dual AAV vectors. The n of eyes analyzed is depicted below each bar. The quantification is depicted as the mean number of apical melanosomes/100 μm, the mean value is depicted above the corresponding bar. sh1−/− neg includes sh1−/− eyes injected with AAV vectors expressing either 5′-( n = 1) or 3′-( n = 2) half of the dual TS vectors, or 5′-half ( n = 2) of the dual hybrid AK vectors (neg total n = 5). Values are represented as mean ± standard error of the mean (s.e.m.). * P ANOVA < 0.05, ** P ANOVA < 0.001.Quantification of the number of rhodopsin gold particles at the PR connecting cilium of sh1 mice 2–3 months following subretinal delivery of dual AAV vectors. The n of eyes and connecting cilia analyzed is depicted below each bar. sh1−/− neg includes sh1−/− eyes injected with AAV vectors expressing either 5′-half of the dual TS vectors ( n = 3) or 5′-half ( n = 2) of the dual hybrid AK vectors (neg total n = 5). The quantification is depicted as the mean number of gold particles per length of connecting cilium, the mean value is depicted above the corresponding bar. Values are represented as mean ± standard error of the mean (s.e.m.). More details on the statistical analysis including specific statistical values can be found in the Statistical analysis paragraph of the Materials and methods section.
Figure 8 Semi-thin retinal sections representative of both sh1+/+ and sh1+/– eyes ( sh1+/+) injected with AAV vectors expressing EGFP and of sh1−/− eyes injected with dual AAV trans-splicing (TS-MYO7A), hybrid AK (AK-MYO7A) or the 5′-or 3′-half vectors (neg), as negative controls. The arrows point at correctly localized melanosomes, the scale bar (10 μm) is depicted in the figure.Quantification of melanosome localization in the RPE villi of sh1 mice 2–3 months following subretinal delivery of dual AAV vectors. The n of eyes analyzed is depicted below each bar. The quantification is depicted as the mean number of apical melanosomes/100 μm, the mean value is depicted above the corresponding bar. sh1−/− neg includes sh1−/− eyes injected with AAV vectors expressing either 5′-( n = 1) or 3′-( n = 2) half of the dual TS vectors, or 5′-half ( n = 2) of the dual hybrid AK vectors (neg total n = 5). Values are represented as mean ± standard error of the mean (s.e.m.). * P ANOVA < 0.05, ** P ANOVA < 0.001.Quantification of the number of rhodopsin gold particles at the PR connecting cilium of sh1 mice 2–3 months following subretinal delivery of dual AAV vectors. The n of eyes and connecting cilia analyzed is depicted below each bar. sh1−/− neg includes sh1−/− eyes injected with AAV vectors expressing either 5′-half of the dual TS vectors ( n = 3) or 5′-half ( n = 2) of the dual hybrid AK vectors (neg total n = 5). The quantification is depicted as the mean number of gold particles per length of connecting cilium, the mean value is depicted above the corresponding bar. Values are represented as mean ± standard error of the mean (s.e.m.). More details on the statistical analysis including specific statistical values can be found in the Statistical analysis paragraph of the Materials and methods section.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

15 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 284

Metadata

Authors
Trapani, I., Colella, P., Sommella, A., Iodice, C., Cesi, G., de Simone, S., Marrocco, E., Rossi, S., Giunti, M., Palfi, A., Farrar, G. J., Polishchuk, R., & Auricchio, A.
Affiliations
  • Telethon Institute Of Genetics And Medicine (IT)
  • University of Campania "Luigi Vanvitelli" (IT)
  • University of Bologna (IT)
  • Trinity College Dublin (IE)
  • Federico II University Hospital (IT)
Corresponding author
Auricchio, Alberto
Venue
EMBO Molecular Medicine
Published
2013-12-16
Volume
6
Issue
2
Pages
194-211
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2137826201
Cited by
269
References
82
Citations by year
2026: 18 · 2025: 30 · 2024: 17 · 2023: 24 · 2022: 18 · 2021: 24 · 2020: 31 · 2019: 22 · 2018: 22 · 2017: 23 · 2016: 9 · 2015: 17 · 2014: 13 · 2013: 1
FWCI
8.85
Type
journal article
Language
en
Open access
Licence
Locations
  • EMBO Molecular Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Funders
  • European Research Council/ERC (282085)
  • European Community's Seventh Framework Programme (242013)
  • NIH (R24 RY019861‐01A)
  • Italian Telethon Foundation (TGM11MT1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
adeno-associated virus, retinal gene therapy, trans-splicing, homologous recombination, hybrid vectors, Stargardt disease, photoreceptors, inherited retinal disease
MeSH terms
Stargardt Disease, Myosin VIIa, Dependovirus, Animals, Disease Models, Animal, Genetic Vectors, Humans, Injections, Lipofuscin, Macular Degeneration, Mice, Inbred C57BL, Myosins, Phenotype, Retina, Rhodopsin, Transduction, Genetic, Gene Transfer Techniques, ATP-Binding Cassette Transporters, Trans-Splicing, Photoreceptor Cells, Vertebrate, Melanosomes, Sus scrofa, Mice, Usher Syndromes, Retinal Pigment Epithelium, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.